162 related articles for article (PubMed ID: 37638539)
1. Population pharmacokinetics of ivermectin after mass drug administration in lymphatic filariasis endemic communities of Tanzania.
Fimbo AM; Mlugu EM; Kitabi EN; Kulwa GS; Iwodyah MA; Mnkugwe RH; Kunambi PP; Malishee A; Kamuhabwa AAR; Minzi OM; Aklillu E
CPT Pharmacometrics Syst Pharmacol; 2023 Dec; 12(12):1884-1896. PubMed ID: 37638539
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetic model of ivermectin in mass drug administration against lymphatic filariasis.
Alshehri A; Chhonker YS; Bala V; Edi C; Bjerum CM; Koudou BG; John LN; Mitjà O; Marks M; King CL; Murry DJ
PLoS Negl Trop Dis; 2023 Jun; 17(6):e0011319. PubMed ID: 37262040
[TBL] [Abstract][Full Text] [Related]
3. Dosing pole recommendations for lymphatic filariasis elimination: A height-weight quantile regression modeling approach.
Goss CW; O'Brian K; Dubray C; Fischer PU; Hardy M; Jambulingam P; King CL; Laman M; Lemoine JF; Robinson LJ; Samuela J; Subramanian S; Supali T; Weil GJ; Schechtman KB
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007541. PubMed ID: 31314753
[TBL] [Abstract][Full Text] [Related]
4. Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Thomsen EK; Sanuku N; Baea M; Satofan S; Maki E; Lombore B; Schmidt MS; Siba PM; Weil GJ; Kazura JW; Fleckenstein LL; King CL
Clin Infect Dis; 2016 Feb; 62(3):334-341. PubMed ID: 26486704
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire.
Edi C; Bjerum CM; Ouattara AF; Chhonker YS; Penali LK; Méité A; Koudou BG; Weil GJ; King CL; Murry DJ
PLoS Negl Trop Dis; 2019 May; 13(5):e0007325. PubMed ID: 31107869
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Lymphatic Filariasis and Treatment Effectiveness of Albendazole/ Ivermectin in Individuals with HIV Co-infection in Southwest-Tanzania.
Kroidl I; Saathof E; Maganga L; Clowes P; Maboko L; Hoerauf A; Makunde WH; Haule A; Mviombo P; Pitter B; Mgeni N; Mabuye J; Kowuor D; Mwingira U; Malecela MN; Löscher T; Hoelscher M
PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004618. PubMed ID: 27070786
[TBL] [Abstract][Full Text] [Related]
7. Community-based trial of annual versus biannual single-dose ivermectin plus albendazole against Wuchereria bancrofti infection in human and mosquito populations: study protocol for a cluster randomised controlled trial.
de Souza DK; Ahorlu CS; Adu-Amankwah S; Otchere J; Mensah SK; Larbi IA; Mensah GE; Biritwum NK; Boakye DA
Trials; 2017 Oct; 18(1):448. PubMed ID: 28969715
[TBL] [Abstract][Full Text] [Related]
8. Impact of annual and semi-annual mass drug administration for Lymphatic Filariasis and Onchocerciasis on Hookworm Infection in Côte d'Ivoire.
Loukouri A; Méité A; Koudou BG; Goss CW; Lew D; Weil GJ; N'Goran EK; Fischer PU
PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008642. PubMed ID: 32976514
[TBL] [Abstract][Full Text] [Related]
9. Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trial.
Laman M; Tavul L; Karl S; Kotty B; Kerry Z; Kumai S; Samuel A; Lorry L; Timinao L; Howard SC; Makita L; John L; Bieb S; Wangi J; Albert JM; Payne M; Weil GJ; Tisch DJ; Bjerum CM; Robinson LJ; King CL
Lancet Infect Dis; 2022 Aug; 22(8):1200-1209. PubMed ID: 35533701
[TBL] [Abstract][Full Text] [Related]
10. Lymphatic filariasis transmission in Rufiji District, southeastern Tanzania: infection status of the human population and mosquito vectors after twelve rounds of mass drug administration.
Jones C; Ngasala B; Derua YA; Tarimo D; Reimer L; Bockarie M; Malecela MN
Parasit Vectors; 2018 Nov; 11(1):588. PubMed ID: 30424781
[TBL] [Abstract][Full Text] [Related]
11. Lymphatic filariasis elimination status: Wuchereria bancrofti infections in human populations and factors contributing to continued transmission after seven rounds of mass drug administration in Masasi District, Tanzania.
Lupenza ET; Gasarasi DB; Minzi OM
PLoS One; 2022; 17(1):e0262693. PubMed ID: 35045109
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of Moxidectin combined with Albendazole or Albendazole plus Diethylcarbamazine for Bancroftian Filariasis.
Chhonker YS; Bjerum C; Bala V; Ouattara AF; Koudou BG; Gabo TP; Alshehri A; Meïté A; Fischer PU; Weil GJ; King CL; Budge PJ; Murry DJ
PLoS Negl Trop Dis; 2023 Aug; 17(8):e0011567. PubMed ID: 37616301
[TBL] [Abstract][Full Text] [Related]
13. Individual Efficacy and Community Impact of Ivermectin, Diethylcarbamazine, and Albendazole Mass Drug Administration for Lymphatic Filariasis Control in Fiji: A Cluster Randomized Trial.
Hardy M; Samuela J; Kama M; Tuicakau M; Romani L; Whitfeld MJ; King CL; Weil GJ; Grobler AC; Robinson LJ; Kaldor JM; Steer AC
Clin Infect Dis; 2021 Sep; 73(6):994-1002. PubMed ID: 33728462
[TBL] [Abstract][Full Text] [Related]
14. Lymphatic filariasis control in Tanzania: effect of six rounds of mass drug administration with ivermectin and albendazole on infection and transmission.
Simonsen PE; Derua YA; Kisinza WN; Magesa SM; Malecela MN; Pedersen EM
BMC Infect Dis; 2013 Jul; 13():335. PubMed ID: 23870103
[TBL] [Abstract][Full Text] [Related]
15. The effect of six rounds of single dose mass treatment with diethylcarbamazine or ivermectin on Wuchereria bancrofti infection and its implications for lymphatic filariasis elimination.
Ramaiah KD; Vanamail P; Pani SP; Yuvaraj J; Das PK
Trop Med Int Health; 2002 Sep; 7(9):767-74. PubMed ID: 12225508
[TBL] [Abstract][Full Text] [Related]
16. The impact of six rounds of single-dose mass administration of diethylcarbamazine or ivermectin on the transmission of Wuchereria bancrofti by Culex quinquefasciatus and its implications for lymphatic filariasis elimination programmes.
Ramaiah KD; Das PK; Vanamail P; Pani SP
Trop Med Int Health; 2003 Dec; 8(12):1082-92. PubMed ID: 14641843
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study.
Dubray CL; Sircar AD; Beau de Rochars VM; Bogus J; Direny AN; Ernest JR; Fayette CR; Goss CW; Hast M; O'Brian K; Pavilus GE; Sabin DF; Wiegand RE; Weil GJ; Lemoine JF
PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008298. PubMed ID: 32511226
[TBL] [Abstract][Full Text] [Related]
18. Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis.
Macfarlane CL; Budhathoki SS; Johnson S; Richardson M; Garner P
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD003753. PubMed ID: 30620051
[TBL] [Abstract][Full Text] [Related]
19. Impact of Ivermectin Mass Drug Administration for Lymphatic Filariasis on Scabies in Eight Villages in Kongwa District, Tanzania.
Martin D; Wiegand R; Goodhew B; Lammie P; Mkocha H; Kasubi M
Am J Trop Med Hyg; 2018 Oct; 99(4):937-939. PubMed ID: 30062986
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the interaction between ivermectin and albendazole following their combined use in lambs.
Alvarez L; Lifschitz A; Entrocasso C; Manazza J; Mottier L; Borda B; Virkel G; Lanusse C
J Vet Pharmacol Ther; 2008 Jun; 31(3):230-9. PubMed ID: 18471144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
